Wealthcare Advisory Partners’s NuVasive, Inc. NUVA Stock Holding History

Wealthcare Advisory Partners’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-170	Closed	-$11K	–	2008
2021 Q1	$11K	Buy	+170	New	+$10.2K	﹤0.01%	1435
2020 Q2	–	Sell	-170	Closed	-$9K	–	1453
2020 Q1	$9K	Hold	170	–	–	﹤0.01%	962
2019 Q4	$13K	Hold	170	–	–	﹤0.01%	884
2019 Q3	$11K	Hold	170	–	–	﹤0.01%	910
2019 Q2	$10K	Hold	170	–	–	﹤0.01%	923
2019 Q1	$10K	Hold	170	–	–	﹤0.01%	828
2018 Q4	$8K	Buy	170 +100	+143%	+$6.01K	﹤0.01%	850
2018 Q3	$5K	Hold	70	–	–	﹤0.01%	1012
2018 Q2	$4K	Hold	70	–	–	﹤0.01%	1040
2018 Q1	$4K	Buy	+70	New	+$3.55K	﹤0.01%	888

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wealthcare Advisory Partners's NUVA Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of NuVasive, Inc. (NUVA) in Q2 2021, closing a stake of 170 shares — an estimated $11K sold.

Wealthcare Advisory Partners first reported a position in NUVA in Q1 2018 and held it in 10 quarters. The position peaked at $13K in Q4 2019. 259 funds tracked by Wall St. Rank hold NUVA as of Q2 2021.

Wealthcare Advisory Partners reported no remaining NuVasive, Inc. position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 170 NuVasive, Inc. shares in Q2 2021, an estimated $11K.
Wealthcare Advisory Partners first reported a position in NuVasive, Inc. in Q1 2018 and held it in 10 quarters.
Wealthcare Advisory Partners's NuVasive, Inc. position peaked at $13K in Q4 2019.
259 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.